[HTML][HTML] Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers
Aberrant DNA methylation has emerged as a hallmark in several cancers and contributes to
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers
A Sathyanarayanan, HM Tanha… - Communications …, 2022 - pubmed.ncbi.nlm.nih.gov
Aberrant DNA methylation has emerged as a hallmark in several cancers and contributes to
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.
A Sathyanarayanan, HM Tanha… - Communications …, 2022 - search.ebscohost.com
Aberrant DNA methylation has emerged as a hallmark in several cancers and contributes to
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
[HTML][HTML] Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers
A Sathyanarayanan, HM Tanha, D Mehta… - Communications …, 2022 - ncbi.nlm.nih.gov
Aberrant DNA methylation has emerged as a hallmark in several cancers and contributes to
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers
A Sathyanarayanan, HM Tanha… - Communications …, 2022 - search.proquest.com
Aberrant DNA methylation has emerged as a hallmark in several cancers and contributes to
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
[引用][C] Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers
A Sathyanarayanan, HM Tanha, D Mehta, DR Nyholt - 2022 - agris.fao.org
Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for
breast and prostate cancers Food and Agriculture Organization of the United Nations Discover …
breast and prostate cancers Food and Agriculture Organization of the United Nations Discover …
Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.
A Sathyanarayanan, HM Tanha, D Mehta… - Communications …, 2022 - europepmc.org
Aberrant DNA methylation has emerged as a hallmark in several cancers and contributes to
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers
A Sathyanarayanan, HM Tanha, D Mehta… - Communications …, 2022 - eprints.qut.edu.au
Aberrant DNA methylation has emerged as a hallmark in several cancers and contributes to
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …
risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based …